Taipei Exchange
03:30:00 28/06/2024 am IST
5-day change
1st Jan Change
36.9
TWD
-1.34%
-0.27%
+11.14%
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2019
March 27, 2020 at 03:08 am IST
BioLASCO Taiwan Co., Ltd. announced earnings results for the full year ended December 31, 2019. For the full year, the company announced sales was TWD 346.686 million compared to TWD 293.704 million a year ago. Operating income was TWD 70.877 million compared to TWD 68.746 million a year ago. Net income was TWD 54.973 million compared to TWD 53.127 million a year ago. Basic earnings per share was TWD 2.19 compared to TWD 2.28 a year ago.
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
14/05
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
20/03
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
09/11
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023
08/23/08
CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend
31/23/31
CI
BioLASCO Taiwan Co., Ltd. Announces Change of Remuneration Committee
12/23/12
CI
BioLASCO Taiwan Co., Ltd. Announces Change of Audit Committee
12/23/12
CI
BioLASCO Taiwan Co., Ltd. Announces Board Changes
12/23/12
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
15/23/15
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022
24/23/24
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022
04/22/04
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
05/22/05
CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on August 26, 2022
05/22/05
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022
05/22/05
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021
24/22/24
CI
BioLASCO Taiwan Co., Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021
06/21/06
CI
BioLASCO Taiwan Co., Ltd. Announces CEO Changes
05/21/05
CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
06/21/06
CI
BioLASCO Taiwan Co., Ltd. Announces Cash Dividend, Payable on September 22, 2021
05/21/05
CI
BioLASCO Taiwan Co., Ltd. Elects Liu, Wei-Ming as Natural-Person Director
05/21/05
CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2020
26/21/26
CI
BioLASCO Taiwan Co., Ltd. Appoints Stacey Yu as Corporate Governance Officer
25/21/25
CI
BioLASCO Taiwan Co., Ltd. Renews Ten-Year Distribution and Propagation Agreement with Charles River Laboratories International, Inc
18/21/18
CI
BioLASCO Taiwan Co., Ltd. Announces Resignation of Chen,Chien-Chang as Director
03/21/03
CI
Biolasco Taiwan Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2020
12/20/12
CI
Duration Auto. 2 months 3 months 6 months 9 months 1 year 2 years 5 years 10 years Max.
Period Day Week
More charts
BioLASCO Taiwan Co., Ltd. is a Taiwan-based company mainly engaged in the production of Specific Pathogen Free (SPF) laboratory animals and the high-value special-mode experimental animals, as well as the introduction and production of highly-applicable disease-mode animals. The company also provides equipment related to feeding, supplies and testing platform, life science research and pharmaceutical development services.
More about the company
1st Jan change
Capi.
+11.14% 29.09M +19.41% 45.51B +38.65% 38.13B -8.62% 38.52B +26.95% 30.74B -13.50% 26.03B +10.74% 25.92B +44.87% 14.13B +34.36% 12.73B -7.14% 11.29B
Other Biotechnology & Medical Research
+951% of historical
More than 20 years
Our Experts
OUR EXPERTS ARE HERE FOR YOU
Monday - Friday 9am-12pm / 2pm-6pm GMT + 1
BIOLASCO TAIWAN CO., LTD. 
